The transglycosylation step of cell wall synthesis is a prime antibiotic target because it is essential and specific to bacteria. Two antibiotics, ramoplanin and moenomycin, target this step by binding to the substrate lipid II and the transglycosylase enzyme, respectively. Here, we compare the ramoplanin and moenomycin stimulons in the Gram-positive model organism Bacillus subtilis. Ramoplanin strongly induces the LiaRS two-component regulatory system, while moenomycin almost exclusively induces genes that are part of the regulon of the extracytoplasmic function (ECF) factor M . Ramoplanin additionally induces the ytrABCDEF and ywoBCD operons, which are not part of a previously characterized antibiotic-responsive regulon. Cluster analysis reveals that these two operons are selectively induced by a subset of cell wall antibiotics that inhibit lipid II function or recycling. Repression of both operons requires YtrA, which recognizes an inverted repeat in front of its own operon and in front of ywoB. These results suggest that YtrA is an additional regulator of cell envelope stress responses.The bacterial cell wall is a unique and vital molecular sieve. It provides the cell with structural strength and protects it from lysis due to high turgor pressures. This makes the cell wall an important target for many antimicrobial compounds (43). The major component of the cell wall is peptidoglycan (PG), an alternating polymer of the amino sugars N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc). GlcNAc and MurNAc are synthesized inside the cell and incorporated, together with a pentapeptide side chain, into the lipid-linked PG precursor designated lipid II. After lipid II is translocated to the outside cell, the GlcNAc-MurNAc-pentapepide portion is inserted and cross-linked to the existing PG by the transglycosylase (TG) and transpeptidase (TP) activities of high-molecular-weight penicillin binding proteins (HMW PBPs).The TG and TP reactions are both excellent drug targets, because they are essential, are easily accessible, and have no equivalent in eukaryotic cells. The TP reaction is specifically targeted by -lactam antibiotics, which covalently modify the enzyme active site. The TG reaction is inhibited by several classes of antibiotics targeting either the substrate or the enzyme. Moenomycin (MOE) is a glycolipid that targets the active site of the TG enzyme (23). Among the TG inhibitors that bind lipid II, the glycopeptides vancomycin, teicoplanin, and ristocetin bind to the terminal D-Ala-D-Ala of the pentapeptide side chain (21, 30). The glycolipodepsipeptide ramoplanin sequesters lipid II at the interface between the extracellular environment and the bacterial membrane and binds the reducing end of the nascent glycan chain (9, 12, 13). The lantibiotic nisin recognizes the diphospho-sugar portion of lipid II (17). Bacitracin, a cyclic dodecylpeptide antibiotic, binds to the undecaprenyl pyrophosphate released after the TG reaction and thereby inhibits the recycling of the key undecaprenyl phosphate li...